(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.08%) $82.74
(0.24%) $1.657
(-0.41%) $2 328.70
(-0.44%) $27.23
(-0.23%) $913.70
(-0.03%) $0.934
(0.02%) $10.99
(-0.01%) $0.802
(0.01%) $92.33
Live Chart Being Loaded With Signals
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs...
Stats | |
---|---|
Today's Volume | 0.00 |
Average Volume | 651 457 |
Market Cap | 0.00 |
EPS | $0 ( 2022-08-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.34 |
ATR14 | $0.324 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-07-01 | Vivo Opportunity, Llc | Sell | 431 947 | Common Stock |
2022-07-01 | Vivo Opportunity, Llc | Sell | 75 749 | Series A Warrants |
2022-07-01 | Orbimed Advisors Llc | Sell | 226 704 | Common Stock |
2022-07-01 | Orbimed Advisors Llc | Sell | 170 437 | Series A Warrants |
2022-07-01 | Ashiya Mona | Sell | 226 704 | Common Stock |
INSIDER POWER |
---|
-97.15 |
Last 99 transactions |
Buy: 4 604 902 | Sell: 10 646 034 |
Volume Correlation
Sierra Oncology Inc Correlation
10 Most Positive Correlations | |
---|---|
IIN | 0.98 |
ECHO | 0.98 |
MLVF | 0.979 |
SIOX | 0.972 |
EXFO | 0.965 |
CDZI | 0.963 |
GLRE | 0.959 |
PROF | 0.958 |
AMYT | 0.958 |
BRAC | 0.954 |
10 Most Negative Correlations | |
---|---|
SNPX | -0.986 |
PIII | -0.966 |
UTME | -0.965 |
BCAB | -0.963 |
MTP | -0.963 |
VORB | -0.961 |
SMFL | -0.961 |
RIVN | -0.955 |
PDBC | -0.95 |
OP | -0.949 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sierra Oncology Inc Correlation - Currency/Commodity
Sierra Oncology Inc Financials
Annual | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-7.14 |
Q1 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.330 |
Q4 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.670 |
Q3 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.10 |
Financial Reports:
No articles found.
Sierra Oncology Inc
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally bioavailable Janus kinase 1 (JAK 1), JAK2, and Activin A receptor type 1 (ACVR1) inhibitor. The company also develops SRA515, a selective bromodomain-containing protein 4 inhibitor; and SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1. It has the license agreements with Carna Biosciences, Inc. to develop and commercialize SRA141, a small molecule kinase inhibitor targeting Cdc7; AstraZeneca AB; and CRT Pioneer Fund LP. The company was formerly known as ProNAi Therapeutics, Inc. and changed its name to Sierra Oncology, Inc. in January 2017. Sierra Oncology, Inc. was incorporated in 2003 and is headquartered in San Mateo, California. As of July 1, 2022, Sierra Oncology, Inc. operates as a subsidiary of GSK plc.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators